Published by Iain Gilbert on 15th April 2024
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".
URL: http://www.digitallook.com/dl/news/story/34221039/...